AIkido Pharma Inc.
One Rockefeller Plaza, 11th Floor
New York, New York 10020
June 16, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Mail Stop 3030
Washington, D.C. 20549
Attention: Ada D. Sarmento
Re: | AIkido Pharma Inc. | |
Registration Statement on Form S-3, as amended | ||
Filed May 11, 2020 | ||
File No. 333-238172 |
Dear Ada:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, AIkido Pharma Inc. hereby requests acceleration of effectiveness of the above referenced Registration Statement on Form S-3 so that it will become effective at 4:00 P.M. EST on June 18, 2020, or as soon as thereafter practicable.
Very truly yours, |
/s/ Anthony Hayes |
Anthony Hayes |
Chief Executive Officer |
cc: | Ellenoff Grossman & Schole LLP | |